ST.27-legal status data

The legal status information displayed below is based on WIPO Standard ST.27 and of a purely informative nature. Binding information on the status of the IP right is only available in DPMAregister (Show details).

DE file number: 60 2019 040 213.9, EP file number: 19 81 9804.6, WO file number: PCT/US2019/037067 (Designation/title: ACYLSULFONAMIDE ALS ANTAGONISTEN DER BCL-FAMILIE ZUR VERWENDUNG BEIM KLINISCHEN MANAGEMENT VON ERKRANKUNGEN, DIE DURCH SENESZENTE ZELLEN VERURSACHT ODER VERMITTELT WERDEN, SOWIE ZUR BEHANDLUNG VON KREBS)

↩ Details

Tabular representation
Current state: Active, Current state: Grant

Key event history
No. Key Event Code Key Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q10 Document published Dec 19, 2019Dec 19, 2019 unchanged
2 Q10 Document published Apr 21, 2021Apr 21, 2021 Filing
3 Q10 Document published Jun 2, 2021Jun 2, 2021Jun 2, 2021 Filing
4 Q10 Document published Oct 25, 2023Oct 25, 2023 Examination
5 Q10 Document published Nov 9, 2023Nov 9, 2023Nov 9, 2023 Examination
6 F10 IP right granted Jul 26, 2024Jul 26, 2024Oct 17, 2024 Grant
Detailed event history
No. Detailed Event Code Detailed Event Name Event Date Effective Date Effective Date sorted ascending Publication Date To Stage
1 Q12 Application published Dec 19, 2019Dec 19, 2019 unchanged
2 Q12 Application published Apr 21, 2021Apr 21, 2021 Filing
3 Q10 Document published Jun 2, 2021Jun 2, 2021Jun 2, 2021 Filing
4 Q10 Document published Oct 25, 2023Oct 25, 2023 Examination
5 Q10 Document published Nov 9, 2023Nov 9, 2023Nov 9, 2023 Examination
6 F10 IP right granted Jul 26, 2024Jul 26, 2024Oct 17, 2024 Grant

Graphical representation

Below you will see a simplified graphical representation of the legal status information, which is based on WIPO Standard ST.27 using the "Overall Patent/SPC Prosecution Model" defined therein.

Graphical representation of the ST.27 legal status data